Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 5th edition, 486 pages Free download

Colorectal Neoplasms

Free Subscription Articles published in Eur J Surg Oncol Retrieve available abstracts of 209 articles: HTML format

Single Articles

November 2020
1. KONSTANTINOU I, Shapey IM, Papamichael D, de Liguori Carino N, et al
   Outcomes following potentially curative therapies for older patients with metastatic colorectal cancer.
   Eur J Surg Oncol. 2020 Nov 12. pii: S0748-7983(20)30900.
   PubMed     Abstract available
   
   
   
2. BIRCH RJ, Downing A, Finan PJ, Howell S, et al
   Improving outcome prediction in individuals with colorectal cancer and diabetes by accurate assessment of vascular complications: Implications for clinical practice.
   Eur J Surg Oncol. 2020 Nov 3. pii: S0748-7983(20)30870.
   PubMed     Abstract available
   
   
   September 2020
3. DIERS J, Baum P, Matthes H, Germer CT, et al
   Mortality and complication management after surgery for colorectal cancer depending on the DKG minimum amounts for hospital volume.
   Eur J Surg Oncol. 2020 Sep 25. pii: S0748-7983(20)30796.
   PubMed     Abstract available
   
   
   
4. NAGOURNEY RA, Evans S, Tran PH, Nagourney AJ, et al
   Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin.
   Eur J Surg Oncol. 2020 Sep 19. pii: S0748-7983(20)30789.
   PubMed     Abstract available
   
   
   
5. ZIMMITTI G, Panettieri E, Ardito F, Mele C, et al
   Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study.
   Eur J Surg Oncol. 2020 Sep 17. pii: S0748-7983(20)30782.
   PubMed     Abstract available
   
   
   
6. OW ZGW, Sim W, Nistala KRY, Ng CH, et al
   Comparing complete mesocolic excision versus conventional colectomy for colon cancer: A systematic review and meta-analysis.
   Eur J Surg Oncol. 2020 Sep 12. pii: S0748-7983(20)30778.
   PubMed     Abstract available
   
   
   
7. EL-SHARKAWY F, Gushchin V, Plerhoples TA, Liu C, et al
   Minimally invasive surgery for T4 colon cancer is associated with better outcomes compared to open surgery in the National Cancer Database.
   Eur J Surg Oncol. 2020 Sep 10. pii: S0748-7983(20)30725.
   PubMed     Abstract available
   
   
   August 2020
8. SORRENTINO L, Serra F, Cabry F, Cauteroq N, et al
   Peritoneal carcinomatosis from colorectal cancer in the pediatric population: Cytoreductive surgery and HIPEC. A systematic review.
   Eur J Surg Oncol. 2020 Aug 27. pii: S0748-7983(20)30713.
   PubMed     Abstract available
   
   
   
9. LO DICO R, Faron M, Yonemura Y, Glehen O, et al
   Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI).
   Eur J Surg Oncol. 2020 Aug 26. pii: S0748-7983(20)30666.
   PubMed    
   
   
   
10. KE J, Liu XH, Jiang XF, He Z, et al
    Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients.
    Eur J Surg Oncol. 2020 Aug 14. pii: S0748-7983(20)30700.
    PubMed     Abstract available
    
    
    July 2020
11. STEENHUIS EGM, Schoenaker IJH, de Groot JWB, Fiebrich HB, et al
    Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study.
    Eur J Surg Oncol. 2020 Jul 25. pii: S0748-7983(20)30655.
    PubMed     Abstract available
    
    
    
12. ARRON MNN, Lier EJ, de Wilt JHW, Stommel MWJ, et al
    Postoperative administration of non-steroidal anti-inflammatory drugs in colorectal cancer surgery does not increase anastomotic leak rate; A systematic review and meta-analysis.
    Eur J Surg Oncol. 2020 Jul 24. pii: S0748-7983(20)30644.
    PubMed     Abstract available
    
    
    June 2020
13. QADERI SM, Swartjes H, Custers JAE, de Wilt JHW, et al
    Health care provider and patient preparedness for alternative colorectal cancer follow-up; a review.
    Eur J Surg Oncol. 2020 Jun 14. pii: S0748-7983(20)30541.
    PubMed     Abstract available
    
    
    
14. LIU Y, Liu J, Kong X, Li H, et al
    SGK2 is overexpressed in colon cancer and promotes epithelial-mesenchymal transition in colon cancer cells.
    Eur J Surg Oncol. 2020 Jun 9. pii: S0748-7983(20)30522.
    PubMed     Abstract available
    
    
    April 2020
15. WISSELINK DD, Klaver CEL, Hompes R, Bemelman WA, et al
    Curative-intent surgery for isolated locoregional recurrence of colon cancer: Review of the literature and institutional experience.
    Eur J Surg Oncol. 2020 Apr 28. pii: S0748-7983(20)30418.
    PubMed     Abstract available
    
    
    
16. KHAN MF, Cahill RA
    Peroperative personalised decision support and analytics for colon cancer surgery- Short report.
    Eur J Surg Oncol. 2020 Apr 21. pii: S0748-7983(20)30406.
    PubMed     Abstract available
    
    
    
17. BAKKERS C, van Erning FN, Rovers KP, Nienhuijs SW, et al
    Long-term survival after hyperthermic intraperitoneal chemotherapy using mitomycin C or oxaliplatin in colorectal cancer patients with synchronous peritoneal metastases: A nationwide comparative study.
    Eur J Surg Oncol. 2020 Apr 18. pii: S0748-7983(20)30415.
    PubMed     Abstract available
    
    
    
18. MIYAMOTO K, Wakabayashi M, Mizusawa J, Nakamura K, et al
    Evaluation of the representativeness and generalizability of Japanese clinical trials for localized rectal/colon cancer: Comparing participants in the Japan Clinical Oncology Group study with patients in Japanese registries.
    Eur J Surg Oncol. 2020 Apr 18. pii: S0748-7983(20)30402.
    PubMed     Abstract available
    
    
    
19. VAN HARTEN MJ, Greenwood EB, Bedrikovetski S, Dudi-Venkata NN, et al
    Minimally invasive surgery in elderly patients with rectal cancer: An analysis of the Bi-National Colorectal Cancer Audit (BCCA).
    Eur J Surg Oncol. 2020 Apr 3. pii: S0748-7983(20)30391.
    PubMed     Abstract available
    
    
    
20. KLOS D, Risko J, Krivackova D, Lovecek M, et al
    Cost analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and the risk factors for their increased cost in a public insurance health care system - Single centre study.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available
    
    
    
21. HENTZEN JEKR, van der Plas WY, Kuipers H, Ramcharan S, et al
    Delta peritoneal cancer index (DeltaPCI): A new dynamic prognostic parameter for survival in patients with colorectal peritoneal metastases.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available
    
    
    
22. BHATT A, Yonemura Y, Mehta S, Benzerdjeb N, et al
    Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases-is it necessary in absence of visible disease?
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available
    
    
    
23. SOMASHEKHAR SP, Yethadka R, Kumar C R, Ashwin KR, et al
    Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available
    
    
    
24. D'HONDT M, Willems E, Parmentier I, Pottel H, et al
    Laparoscopic liver resection for liver tumours in proximity to major vasculature: A single-center comparative study.
    Eur J Surg Oncol. 2020;46.
    PubMed     Abstract available
    
    
    March 2020
25. MILONE M, Degiuli M, Allaix ME, Ammirati CA, et al
    Mid-transverse colon cancer and extended versus transverse colectomy: Results of the Italian society of surgical oncology colorectal cancer network (SICO CCN) multicenter collaborative study.
    Eur J Surg Oncol. 2020 Mar 19. pii: S0748-7983(20)30006.
    PubMed     Abstract available
    
    
    
26. ARO R, Makarainen-Uhlback E, Ammala N, Rautio T, et al
    The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients - A retrospective register study.
    Eur J Surg Oncol. 2020 Mar 17. pii: S0748-7983(20)30353.
    PubMed     Abstract available
    
    
    
27. GHIASLOO M, Pavlenko D, Verhaeghe M, Van Langenhove Z, et al
    Surgical treatment of stage IV colorectal cancer with synchronous liver metastases: A systematic review and network meta-analysis.
    Eur J Surg Oncol. 2020 Mar 6. pii: S0748-7983(20)30148.
    PubMed     Abstract available
    
    
    
28. ARSONIADIS EG, Finlayson E, Potenti F
    Is there a role for specialized geriatric centers in treating geriatric cancer patients?
    Eur J Surg Oncol. 2020;46:383-386.
    PubMed     Abstract available
    
    
    
29. SEVAK S, Gregoir T, Wolthuis A, Albert M, et al
    How can we utilize local excision to help, not harm, geriatric patients with rectal cancer?
    Eur J Surg Oncol. 2020;46:344-348.
    PubMed     Abstract available
    
    
    
30. HAAK HE, Maas M, Lambregts DMJ, Beets-Tan RGH, et al
    Is watch and wait a safe and effective way to treat rectal cancer in older patients?
    Eur J Surg Oncol. 2020;46:358-362.
    PubMed     Abstract available
    
    
    
31. ASOGLU O, Tokmak H, Bakir B, Demir G, et al
    The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases.
    Eur J Surg Oncol. 2020;46:402-409.
    PubMed     Abstract available
    
    
    
32. MILLAN M, Renau-Escrig AI
    Minimizing the impact of colorectal surgery in the older patient: The role of enhanced recovery programs in older patients.
    Eur J Surg Oncol. 2020;46:338-343.
    PubMed     Abstract available
    
    
    
33. MYINT AS, Gerard JP
    Role of radiotherapy in the treatment of rectal cancer in older patients.
    Eur J Surg Oncol. 2020;46:349-357.
    PubMed     Abstract available
    
    
    
34. KOLARSICK PA, Sacchi M, Spinelli A, Wexner SD, et al
    Minimizing the impact of colorectal surgery in the older patient: The role of minimally invasive surgery in the geriatric population.
    Eur J Surg Oncol. 2020;46:333-337.
    PubMed     Abstract available
    
    
    
35. DETERING R, de Neree Tot Babberich MPM, Bos ACRK, Dekker JWT, et al
    Nationwide analysis of hospital variation in preoperative radiotherapy use for rectal cancer following guideline revision.
    Eur J Surg Oncol. 2020;46:486-494.
    PubMed     Abstract available
    
    
    
36. DENOST Q, Bousser V, Morin-Porchet C, Vincent C, et al
    The development of a regional referral pathway for locally recurrent rectal cancer: A Delphi consensus study.
    Eur J Surg Oncol. 2020;46:470-475.
    PubMed     Abstract available
    
    
    
37. HAGEMANS JAW, van Rees JM, Alberda WJ, Rothbarth J, et al
    Locally recurrent rectal cancer; long-term outcome of curative surgical and non-surgical treatment of 447 consecutive patients in a tertiary referral centre.
    Eur J Surg Oncol. 2020;46:448-454.
    PubMed     Abstract available
    
    
    
38. LORENZON L, Evrard S, Beets G, Gonzalez-Moreno S, et al
    Global variation in the long-term outcomes of ypT0 rectal cancers.
    Eur J Surg Oncol. 2020;46:420-428.
    PubMed     Abstract available
    
    
    
39. BASHIR MOHAMED K, Hansen CH, Krarup PM, Fransgard T, et al
    The impact of anastomotic leakage on recurrence and long-term survival in patients with colonic cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2020;46:439-447.
    PubMed     Abstract available
    
    
    
40. FAHIM M, Dijksman LM, van Kessel CS, Smeeing DPJ, et al
    Promising results of a new treatment in patients with bowel obstruction in colorectal surgery.
    Eur J Surg Oncol. 2020;46:415-419.
    PubMed     Abstract available
    
    
    
41. ZHANG YX, Liu HY, Jiang B, Wang WY, et al
    Stepwise neoadjuvant chemoradiotherapy in the management of mid-low locally advanced rectal cancer.
    Eur J Surg Oncol. 2020;46:410-414.
    PubMed     Abstract available
    
    
    
42. ROSTOFT S, Hamaker ME
    Basic geriatric principles for colorectal surgeons: How to optimize assessment and care of older patients in the perioperative period.
    Eur J Surg Oncol. 2020;46:310-315.
    PubMed     Abstract available
    
    
    
43. SHAHROKNI A, Alexander K
    What will perioperative geriatric assessment for older cancer patients look like in 2025? Advantages and limitations of new technologies in geriatric assessment.
    Eur J Surg Oncol. 2020;46:305-309.
    PubMed     Abstract available
    
    
    February 2020
44. BREUGOM AJ, Bastiaannet E, Guren MG, Korner H, et al
    Treatment strategies and overall survival for incurable metastatic colorectal cancer - A EURECCA international comparison including 21,196 patients from the Netherlands and Norway.
    Eur J Surg Oncol. 2020 Feb 29. pii: S0748-7983(20)30106.
    PubMed     Abstract available
    
    
    
45. FOPPA C, Ng SC, Montorsi M, Spinelli A, et al
    Anastomotic leak in colorectal cancer patients: New insights and perspectives.
    Eur J Surg Oncol. 2020 Feb 24. pii: S0748-7983(20)30129.
    PubMed     Abstract available
    
    
    
46. MINICOZZI P, Vicentini M, Innos K, Castro C, et al
    Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study.
    Eur J Surg Oncol. 2020 Feb 21. pii: S0748-7983(20)30125.
    PubMed     Abstract available
    
    
    
47. VAN GRONINGEN JT, Ceyisakar IE, Gietelink L, Henneman D, et al
    Identifying best performing hospitals in colorectal cancer care; is it possible?
    Eur J Surg Oncol. 2020 Feb 21. pii: S0748-7983(20)30126.
    PubMed     Abstract available
    
    
    January 2020
48. MONTRONI I, Saur NM
    Modern, multidisciplinary colorectal cancer care in older patients: Striking a balance between cancer treatment and patient-centered care.
    Eur J Surg Oncol. 2020 Jan 22. pii: S0748-7983(20)30025.
    PubMed    
    
    
    
49. CARLI F, Bessissow A, Awasthi R, Liberman S, et al
    Modern multidisciplinary colorectal cancer care in the elderly: Striking a balance between cancer treatment and patient-centered care.
    Eur J Surg Oncol. 2020 Jan 11. pii: S0748-7983(20)30001.
    PubMed     Abstract available
    
    
    
50. KETELAERS SHJ, Fahim M, Rutten HJT, Smits AB, et al
    When and how should surgery be performed in senior colorectal cancer patients?
    Eur J Surg Oncol. 2020 Jan 9. pii: S0748-7983(20)30007.
    PubMed     Abstract available
    
    
    
51. GHIGNONE F, Hernandez P, Mahmoud NN, Ugolini G, et al
    Functional recovery in senior adults undergoing surgery for colorectal cancer: Assessment tools and strategies to preserve functional status.
    Eur J Surg Oncol. 2020 Jan 8. pii: S0748-7983(20)30003.
    PubMed     Abstract available
    
    
    
52. PAPAMICHAEL D, Hernandez P, Mistry R, Xenophontos E, et al
    Adjuvant chemotherapy in patients with colorectal cancer. Is there a role in the older adult?
    Eur J Surg Oncol. 2020 Jan 8. pii: S0748-7983(20)30002.
    PubMed     Abstract available
    
    
    
53. ZATTONI D, Christoforidis D
    How best to palliate and treat emergency conditions in geriatric patients with colorectal cancer.
    Eur J Surg Oncol. 2020 Jan 2. pii: S0748-7983(19)31510.
    PubMed     Abstract available
    
    
    
54. KAWADA T
    Characteristics in patients with symptomatic colorectal carcinomas and those detected by screening.
    Eur J Surg Oncol. 2020;46:220.
    PubMed    
    
    
    
55. REDONDO M, Tellez T
    Reply to: Characteristics in patients with symptomatic colorectal carcinomas and those detected by screening'.
    Eur J Surg Oncol. 2020;46:221.
    PubMed    
    
    
    
56. SIDDIQUI J, Brown K, Zahid A, Young CJ, et al
    Current practices and barriers to referral for cytoreductive surgery and HIPEC among colorectal surgeons: A binational survey.
    Eur J Surg Oncol. 2020;46:166-172.
    PubMed     Abstract available
    
    
    
57. SHEN Z, Bu Z, Li A, Lu J, et al
    Multicenter study of surgical and oncologic outcomes of extra-levator versus conventional abdominoperineal excision for lower rectal cancer.
    Eur J Surg Oncol. 2020;46:115-122.
    PubMed     Abstract available
    
    
    
58. DULSKAS A, Pilvelis A
    Oncologic outcome of mixed adenoneuroendocrine carcinoma (MANEC): A single center case series.
    Eur J Surg Oncol. 2020;46:105-107.
    PubMed     Abstract available
    
    
    
59. IWAI T, Yamada T, Takahashi G, Takeda K, et al
    Circulating cell-free long DNA fragments predict post-hepatectomy recurrence of colorectal liver metastases.
    Eur J Surg Oncol. 2020;46:108-114.
    PubMed     Abstract available
    
    
    
60. TAPPER J, Arver S, Holm T, Bottai M, et al
    Acute primary testicular failure due to radiotherapy increases risk of severe postoperative adverse events in rectal cancer patients.
    Eur J Surg Oncol. 2020;46:98-104.
    PubMed     Abstract available
    
    
    December 2019
61. TINGUELY P, Dal G, Bottai M, Nilsson H, et al
    Microwave ablation versus resection for colorectal cancer liver metastases - A propensity score analysis from a population-based nationwide registry.
    Eur J Surg Oncol. 2019 Dec 2. pii: S0748-7983(19)31495.
    PubMed     Abstract available
    
    
    November 2019
62. GRASS F, Behm KT, Duchalais E, Crippa J, et al
    Impact of delay to surgery on survival in stage I-III colon cancer.
    Eur J Surg Oncol. 2019 Nov 28. pii: S0748-7983(19)31464.
    PubMed     Abstract available
    
    
    
63. SOUWER ET, Moos SI, van Rooden CJ, Bijlsma AY, et al
    Physical performance has a strong association with poor surgical outcome in older patients with colorectal cancer.
    Eur J Surg Oncol. 2019 Nov 28. pii: S0748-7983(19)31463.
    PubMed     Abstract available
    
    
    
64. HAGG S, Jylhava J
    Should we invest in biological age predictors to treat colorectal cancer in the older adults?
    Eur J Surg Oncol. 2019 Nov 8. pii: S0748-7983(19)30926.
    PubMed     Abstract available
    
    
    October 2019
65. BAATEN ICPA, West NP, Quyn AJ, Seymour MT, et al
    Colorectal cancer peritoneal metastases: Biology, treatment and next steps.
    Eur J Surg Oncol. 2019 Oct 31. pii: S0748-7983(19)30915.
    PubMed     Abstract available
    
    
    
66. OLTHOF PB, van Dam JL, Groen JV, Ophuis CO, et al
    Screening for colorectal cancer after pancreatoduodenectomy for ampullary cancer.
    Eur J Surg Oncol. 2019 Oct 11. pii: S0748-7983(19)30894.
    PubMed     Abstract available
    
    
    
67. QADERI SM, Vromen H, Dekker HM, Stommel MWJ, et al
    Development and implementation of a remote follow-up plan for colorectal cancer patients.
    Eur J Surg Oncol. 2019 Oct 11. pii: S0748-7983(19)30895.
    PubMed     Abstract available
    
    
    September 2019
68. TAIBI A, Lo Dico R, Kaci R, Naneix AL, et al
    Evaluation of a new histological grading system for assessing the response to chemotherapy of peritoneal metastases from colorectal cancer: A mouse model study.
    Eur J Surg Oncol. 2019 Sep 12. pii: S0748-7983(19)30674.
    PubMed     Abstract available
    
    
    July 2019
69. DOOLIN JW, Halpin M, Berry JL, Hshieh T, et al
    Why focus on patient-reported outcome measures in older colorectal cancer patients?
    Eur J Surg Oncol. 2019 Jul 25. pii: S0748-7983(19)30586.
    PubMed     Abstract available
    
    
    
70. SOARES AS, Lovat LB, Chand M
    Intracorporeal lymph node mapping in colon cancer surgery.
    Eur J Surg Oncol. 2019 Jul 16. pii: S0748-7983(19)30550.
    PubMed     Abstract available
    
    
    
71. STROUS MTA, Janssen-Heijnen MLG, Vogelaar FJ
    Impact of therapeutic delay in colorectal cancer on overall survival and cancer recurrence - is there a safe timeframe for prehabilitation?
    Eur J Surg Oncol. 2019 Jul 4. pii: S0748-7983(19)30546.
    PubMed     Abstract available
    
    
    June 2019
72. REHMAN AH, Jones RP, Poston G
    Prognostic and predictive markers in liver limited stage IV colorectal cancer.
    Eur J Surg Oncol. 2019 Jun 27. pii: S0748-7983(19)30536.
    PubMed     Abstract available
    
    
    
73. KETELAERS SHJ, Orsini RG, Burger JWA, Nieuwenhuijzen GAP, et al
    Significant improvement in postoperative and 1-year mortality after colorectal cancer surgery in recent years.
    Eur J Surg Oncol. 2019 Jun 13. pii: S0748-7983(19)30511.
    PubMed     Abstract available
    
    
    
74. ONERUP A, Angenete E, Bonfre P, Borjesson M, et al
    Self-assessed preoperative level of habitual physical activity predicted postoperative complications after colorectal cancer surgery: A prospective observational cohort study.
    Eur J Surg Oncol. 2019 Jun 12. pii: S0748-7983(19)30513.
    PubMed     Abstract available
    
    
    
75. GIESEN LJX, van Erning FN, Vissers PAJ, Maas HAAM, et al
    Inter-hospital variation in resection rates of colon cancer in the Netherlands: A nationwide study.
    Eur J Surg Oncol. 2019 Jun 8. pii: S0748-7983(19)30506.
    PubMed     Abstract available
    
    
    May 2019
76. GKEKAS I, Novotny J, Fabian P, Nemecek R, et al
    Deficient mismatch repair as a prognostic marker in stage II colon cancer patients.
    Eur J Surg Oncol. 2019 May 28. pii: S0748-7983(19)30461.
    PubMed     Abstract available
    
    
    
77. KATAOKA K, Ysebaert H, Shiozawa M, Reynders D, et al
    Prognostic significance of number versus location of positive mesenteric nodes in stage iii colon cancer.
    Eur J Surg Oncol. 2019 May 24. pii: S0748-7983(19)30460.
    PubMed     Abstract available
    
    
    
78. MCSORLEY ST, Dolan RD, Roxburgh CS, Horgan PG, et al
    Possible dose dependent effect of perioperative dexamethasone and laparoscopic surgery on the postoperative systemic inflammatory response and complications following surgery for colon cancer.
    Eur J Surg Oncol. 2019 May 20. pii: S0748-7983(19)30458.
    PubMed     Abstract available
    
    
    
79. VALLANCE AE, Harji D, Fearnhead NS
    Making an IMPACT: A priority setting consultation exercise to improve outcomes in patients with locally advanced, recurrent and metastatic colorectal cancer.
    Eur J Surg Oncol. 2019 May 7. pii: S0748-7983(19)30397.
    PubMed     Abstract available
    
    
    
80. DRAKE TM, Soreide K
    Cancer epigenetics in solid organ tumours: A primer for surgical oncologists.
    Eur J Surg Oncol. 2019;45:736-746.
    PubMed     Abstract available
    
    
    April 2019
81. SCHRAM A, Ferreira V, Minnella EM, Awasthi R, et al
    In-hospital resistance training to encourage early mobilization for enhanced recovery programs after colorectal cancer surgery: A feasibility study.
    Eur J Surg Oncol. 2019 Apr 25. pii: S0748-7983(19)30407.
    PubMed     Abstract available
    
    
    
82. BOS ACRK, Kortbeek D, van Erning FN, Zimmerman DDE, et al
    Postoperative mortality in elderly patients with colorectal cancer: The impact of age, time-trends and competing risks of dying.
    Eur J Surg Oncol. 2019 Apr 25. pii: S0748-7983(19)30412.
    PubMed     Abstract available
    
    
    
83. SINGH B, Singh G, Alzahrani N, Arrowaili A, et al
    Long term survival and perioperative propensity score matched outcomes in diaphragmatic interventions in cytoreductive surgery + intra-peritoneal chemotherapy.
    Eur J Surg Oncol. 2019;45:620-624.
    PubMed     Abstract available
    
    
    
84. HAGEMANS JAW, Alberda WJ, Verstegen M, de Wilt JHW, et al
    Hospital volume and outcome in rectal cancer patients; results of a population-based study in the Netherlands.
    Eur J Surg Oncol. 2019;45:613-619.
    PubMed     Abstract available
    
    
    
85. PENNINGS JP, de Haas RJ, Murshid KJA, de Jong KP, et al
    FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
    Eur J Surg Oncol. 2019;45:606-612.
    PubMed     Abstract available
    
    
    
86. TERSTEEG JJC, van Esch LM, Gobardhan PD, Kint PAM, et al
    Early local recurrence and one-year mortality of rectal cancer after restricting the neoadjuvant therapy regime.
    Eur J Surg Oncol. 2019;45:597-605.
    PubMed     Abstract available
    
    
    
87. NIEROP PMH, Verseveld M, Galjart B, Rothbarth J, et al
    The liver-first approach for locally advanced rectal cancer and synchronous liver metastases.
    Eur J Surg Oncol. 2019;45:591-596.
    PubMed     Abstract available
    
    
    
88. TUFO A, Dunne DF, Manu N, Lacasia C, et al
    Changing outlook for colorectal liver metastasis resection in the elderly.
    Eur J Surg Oncol. 2019;45:635-643.
    PubMed     Abstract available
    
    
    
89. GRASS JK, Perez DR, Izbicki JR, Reeh M, et al
    Systematic review analysis of robotic and transanal approaches in TME surgery- A systematic review of the current literature in regard to challenges in rectal cancer surgery.
    Eur J Surg Oncol. 2019;45:498-509.
    PubMed     Abstract available
    
    
    
90. D'SOUZA N, Lord A, Shaw A, Abulafi M, et al
    Meta-analysis of oncological outcomes of sigmoid cancers: A hidden epidemic of R1 "palliative" resections.
    Eur J Surg Oncol. 2019;45:489-497.
    PubMed     Abstract available
    
    
    March 2019
91. DAZA JF, Solis NM, Parpia S, Gallinger S, et al
    A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases.
    Eur J Surg Oncol. 2019 Mar 21. pii: S0748-7983(19)30353.
    PubMed     Abstract available
    
    
    
92. BONIFACIO C, Vigano L, Felisaz P, Lopci E, et al
    Diffusion-weighted imaging and loco-regional N staging of patients with colorectal liver metastases.
    Eur J Surg Oncol. 2019;45:347-352.
    PubMed     Abstract available
    
    
    
93. SVERRISSON I, Folkvaljon F, Chabok A, Stattin P, et al
    Anastomotic leakage after anterior resection in patients with rectal cancer previously irradiated for prostate cancer.
    Eur J Surg Oncol. 2019;45:341-346.
    PubMed     Abstract available
    
    
    
94. KOMORI K, Fujita S, Mizusawa J, Kanemitsu Y, et al
    Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).
    Eur J Surg Oncol. 2019;45:336-340.
    PubMed     Abstract available
    
    
    
95. VAN DER WERF LR, Wassenaar E, de Niet A, Lalezari F, et al
    The impact of radiological retroperitoneal lymphadenopathy on survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases.
    Eur J Surg Oncol. 2019;45:376-382.
    PubMed     Abstract available
    
    
    
96. OEMRAWSINGH A, de Boer NL, Brandt-Kerkhof ARM, Verhoef C, et al
    Short-term complications in elderly patients undergoing CRS and HIPEC: A single center's initial experience.
    Eur J Surg Oncol. 2019;45:383-388.
    PubMed     Abstract available
    
    
    
97. CEELEN W
    HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?
    Eur J Surg Oncol. 2019;45:400-402.
    PubMed     Abstract available
    
    
    
98. CHUNG E, Kang D, Lee HS, Cho ES, et al
    Accuracy of pelvic MRI in measuring tumor height in rectal cancer patients with or without preoperative chemoradiotherapy.
    Eur J Surg Oncol. 2019;45:324-330.
    PubMed     Abstract available
    
    
    
99. GREMONPREZ F, Gossye H, Ceelen W
    Use of hyperthermia versus normothermia during intraperitoneal chemoperfusion with oxaliplatin for colorectal peritoneal carcinomatosis: A propensity score matched analysis.
    Eur J Surg Oncol. 2019;45:366-370.
    PubMed     Abstract available
    
    
    February 2019
100. MCSORLEY ST, Tham A, Steele CW, Dolan RD, et al
     Quantitative data on red cell measures of iron status and their relation to the magnitude of the systemic inflammatory response and survival in patients with colorectal cancer.
     Eur J Surg Oncol. 2019 Feb 27. pii: S0748-7983(19)30300.
     PubMed     Abstract available
     
     
     
101. ARKENBOSCH JHC, van Erning FN, Rutten HJ, Zimmerman D, et al
     The association between body mass index and postoperative complications, 30-day mortality and long-term survival in Dutch patients with colorectal cancer.
     Eur J Surg Oncol. 2019;45:160-166.
     PubMed     Abstract available
     
     
     
102. THOMAS G, van Heinsbergen M, van der Heijden J, Slooter G, et al
     Awareness and management of low anterior resection syndrome: A Dutch national survey among colorectal surgeons and specialized nurses.
     Eur J Surg Oncol. 2019;45:174-179.
     PubMed     Abstract available
     
     
     December 2018
103. QUENET F
     Colorectal peritoneal carcinomatosis: What is the future of HIPEC?
     Eur J Surg Oncol. 2018;44:1847-1848.
     PubMed    
     
     
     
104. WANG XJ, Chi P, Zhang YY, Lin HM, et al
     Survival outcome of adjuvant radiotherapy after local excision for T2 early rectal cancer: An analysis based on the surveillance, epidemiology, and end result registry database.
     Eur J Surg Oncol. 2018;44:1865-1872.
     PubMed     Abstract available
     
     
     
105. HAMMARSTROM K, Mezheyeuski A, Korsavidou Hult N, Sjoblom T, et al
     Stage distribution utilizing magnetic resonance imaging in an unselected population of primary rectal cancers.
     Eur J Surg Oncol. 2018;44:1858-1864.
     PubMed     Abstract available
     
     
     
106. EVRARD S
     Autopsy of an expert consensus: End of hyperthermic intraperitoneal chemotherapy in colorectal carcinomatosis.
     Eur J Surg Oncol. 2018;44:1845-1846.
     PubMed    
     
     
     
107. BUSHATI M, Rovers KP, Sommariva A, Sugarbaker PH, et al
     The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).
     Eur J Surg Oncol. 2018;44:1942-1948.
     PubMed     Abstract available
     
     
     November 2018
108. LORIMIER G, Seegers V, Coudert M, Dupoiron D, et al
     Prolonged perioperative thoracic epidural analgesia may improve survival after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A comparative study.
     Eur J Surg Oncol. 2018;44:1824-1831.
     PubMed     Abstract available
     
     
     
109. MONTRONI I, Ugolini G, Saur NM, Spinelli A, et al
     Personalized management of elderly patients with rectal cancer: Expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology, International Society of Geriatric Oncology, and American College of Surgeons Comm
     Eur J Surg Oncol. 2018;44:1685-1702.
     PubMed     Abstract available
     
     
     October 2018
110. FENG Y, Li Y, Huang D, Cai S, et al
     HER2 as a potential biomarker guiding adjuvant chemotherapy in stage II colorectal cancer.
     Eur J Surg Oncol. 2018 Oct 19. pii: S0748-7983(18)31462.
     PubMed     Abstract available
     
     
     
111. KLAVER CEL, Wasmann KATGM, Verstegen M, van der Bilt JDW, et al
     Postoperative abdominal infections after resection of T4 colon cancer increase the risk of intra-abdominal recurrence.
     Eur J Surg Oncol. 2018 Oct 18. pii: S0748-7983(18)31435.
     PubMed     Abstract available
     
     
     
112. SENORE C, Giovo I, Ribaldone DG, Ciancio A, et al
     Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: Outcome and treatment quality indicators.
     Eur J Surg Oncol. 2018 Oct 16. pii: S0748-7983(18)31428.
     PubMed     Abstract available
     
     
     
113. STERPETTI AV
     "A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumor" by DP Harji et al.
     Eur J Surg Oncol. 2018 Oct 11. pii: S0748-7983(18)31444.
     PubMed    
     
     
     
114. HANGAARD HANSEN C, Gogenur M, Tvilling Madsen M, Gogenur I, et al
     The effect of time from diagnosis to surgery on oncological outcomes in patients undergoing surgery for colon cancer: A systematic review.
     Eur J Surg Oncol. 2018;44:1479-1485.
     PubMed     Abstract available
     
     
     
115. MERTZ-PETERSEN M, Piper TB, Kleif J, Ferm L, et al
     Triage for selection to colonoscopy?
     Eur J Surg Oncol. 2018;44:1539-1541.
     PubMed     Abstract available
     
     
     
116. PEDERSEN TB, Gocht-Jensen P, Klein MF
     30-day and long-term outcome following salvage surgery for squamous cell carcinoma of the anus.
     Eur J Surg Oncol. 2018;44:1518-1521.
     PubMed     Abstract available
     
     
     
117. SCHMIDT T, Nienhuser H, Kuna C, Klose J, et al
     Prognostic indicators lose their value with repeated resection of colorectal liver metastases.
     Eur J Surg Oncol. 2018;44:1610-1618.
     PubMed     Abstract available
     
     
     
118. HUBERT C, Lucidi V, Weerts J, Dili A, et al
     Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases.
     Eur J Surg Oncol. 2018;44:1532-1538.
     PubMed     Abstract available
     
     
     
119. HAGEMANS JAW, Rothbarth J, Kirkels WJ, Boormans JL, et al
     Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
     Eur J Surg Oncol. 2018;44:1548-1554.
     PubMed     Abstract available
     
     
     
120. BOLMSTRAND B, Nilsson PJ, Holm T, Buchli C, et al
     Patterns of complications following urinary tract reconstruction after multivisceral surgery in colorectal and anal cancer.
     Eur J Surg Oncol. 2018;44:1513-1517.
     PubMed     Abstract available
     
     
     
121. OLTHOF PB, Schnitzbauer AA, Schadde E
     The HPB controversy of the decade: 2007-2017 - Ten years of ALPPS.
     Eur J Surg Oncol. 2018;44:1624-1627.
     PubMed     Abstract available
     
     
     September 2018
122. SOUWER ETD, Bastiaannet E, de Bruijn S, Breugom AJ, et al
     Comprehensive multidisciplinary care program for elderly colorectal cancer patients: "From prehabilitation to independence".
     Eur J Surg Oncol. 2018 Sep 8. pii: S0748-7983(18)31304.
     PubMed     Abstract available
     
     
     
123. LI JD, Xu XF, Yu JJ, Yang T, et al
     Is obesity a determinant of perioperative and postoperative outcome in patients following colorectal cancer surgery?
     Eur J Surg Oncol. 2018 Sep 6. pii: S0748-7983(18)31294.
     PubMed    
     
     
     
124. POELEMEIJER YQM, Detering R, Wouters MWJM
     Reply to "Is obesity a determinant of perioperative and postoperative outcome in patients following colorectal cancer surgery?"
     Eur J Surg Oncol. 2018 Sep 6. pii: S0748-7983(18)31293.
     PubMed    
     
     
     
125. LIBERALE G, Bohlok A, Bormans A, Bouazza F, et al
     Indocyanine green fluorescence imaging for sentinel lymph node detection in colorectal cancer: A systematic review.
     Eur J Surg Oncol. 2018;44:1301-1306.
     PubMed     Abstract available
     
     
     
126. BREUGOM AJ, Bastiaannet E, Boelens PG, Van Eycken E, et al
     Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania.
     Eur J Surg Oncol. 2018;44:1338-1343.
     PubMed     Abstract available
     
     
     
127. VAN DER HEIJDEN JAG, Thomas G, Caers F, van Dijk WA, et al
     What you should know about the low anterior resection syndrome - Clinical recommendations from a patient perspective.
     Eur J Surg Oncol. 2018;44:1331-1337.
     PubMed     Abstract available
     
     
     August 2018
128. BREUGOM AJ, Bastiaannet E, Dekker JWT, Wouters MWJM, et al
     Decrease in 30-day and one-year mortality over time in patients aged >/=75 years with stage I-III colon cancer: A population-based study.
     Eur J Surg Oncol. 2018 Aug 29. pii: S0748-7983(18)31284.
     PubMed     Abstract available
     
     
     
129. WESTBERG K, Martling A
     Reply to: Management of locally recurrent rectal cancer.
     Eur J Surg Oncol. 2018;44:1282.
     PubMed    
     
     
     
130. HUREIBI K
     Management of locally recurrent rectal cancer.
     Eur J Surg Oncol. 2018;44:1281.
     PubMed    
     
     
     
131. WU J, Wang F, Liu X, Zhang T, et al
     Correlation of IDH1 and B7H3 expression with prognosis of CRC patients.
     Eur J Surg Oncol. 2018;44:1254-1260.
     PubMed     Abstract available
     
     
     
132. VAN HEINSBERGEN M, Janssen-Heijnen ML, Leijtens JW, Slooter GD, et al
     Bowel dysfunction after sigmoid resection underestimated: Multicentre study on quality of life after surgery for carcinoma of the rectum and sigmoid.
     Eur J Surg Oncol. 2018;44:1261-1267.
     PubMed     Abstract available
     
     
     
133. CHINO A, Konishi T, Ogura A, Kawachi H, et al
     Endoscopic criteria to evaluate tumor response of rectal cancer to neoadjuvant chemoradiotherapy using magnifying chromoendoscopy.
     Eur J Surg Oncol. 2018;44:1247-1253.
     PubMed     Abstract available
     
     
     
134. MARIATHASAN AB, Boye K, Giercksky KE, Brennhovd B, et al
     Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement.
     Eur J Surg Oncol. 2018;44:1226-1232.
     PubMed     Abstract available
     
     
     
135. BLOK RD, Stam R, Westerduin E, Borstlap WAA, et al
     Impact of an institutional change from routine to highly selective diversion of a low anastomosis after TME for rectal cancer.
     Eur J Surg Oncol. 2018;44:1220-1225.
     PubMed     Abstract available
     
     
     July 2018
136. OMMUNDSEN N, Nesbakken A, Wyller TB, Skovlund E, et al
     Post-discharge complications in frail older patients after surgery for colorectal cancer.
     Eur J Surg Oncol. 2018 Jul 7. pii: S0748-7983(18)31168.
     PubMed     Abstract available
     
     
     
137. MEGE D, Manceau G, Beyer-Berjot L, Bridoux V, et al
     Surgical management of obstructive right-sided colon cancer at a national level results of a multicenter study of the French Surgical Association in 776 patients.
     Eur J Surg Oncol. 2018 Jul 6. pii: S0748-7983(18)31171.
     PubMed     Abstract available
     
     
     
138. NAZZANI S, Preisser F, Mazzone E, Tian Z, et al
     In-hospital length of stay after major surgical oncological procedures.
     Eur J Surg Oncol. 2018;44:969-974.
     PubMed     Abstract available
     
     
     
139. SUGARBAKER PH
     The hepatic bridge.
     Eur J Surg Oncol. 2018;44:1083-1086.
     PubMed     Abstract available
     
     
     
140. ROMBOUTS AJM, Hugen N, Verhoeven RHA, Elferink MAG, et al
     Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients.
     Eur J Surg Oncol. 2018;44:1018-1024.
     PubMed     Abstract available
     
     
     
141. TRENTI L, Galvez A, Biondo S, Solis A, et al
     Quality of life and anterior resection syndrome after surgery for mid to low rectal cancer: A cross-sectional study.
     Eur J Surg Oncol. 2018;44:1031-1039.
     PubMed     Abstract available
     
     
     
142. HOENDERVANGERS S, Couwenberg AM, Intven MPW, van Grevenstein WMU, et al
     Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
     Eur J Surg Oncol. 2018;44:1013-1017.
     PubMed     Abstract available
     
     
     
143. BERARDI G, De Man M, Laurent S, Smeets P, et al
     Radiologic and pathologic response to neoadjuvant chemotherapy predicts survival in patients undergoing the liver-first approach for synchronous colorectal liver metastases.
     Eur J Surg Oncol. 2018;44:1069-1077.
     PubMed     Abstract available
     
     
     
144. ENBLAD M, Graf W, Birgisson H
     Risk factors for appendiceal and colorectal peritoneal metastases.
     Eur J Surg Oncol. 2018;44:997-1005.
     PubMed     Abstract available
     
     
     
145. NOWACKI M, Alyami M, Villeneuve L, Mercier F, et al
     Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study.
     Eur J Surg Oncol. 2018;44:991-996.
     PubMed     Abstract available
     
     
     
146. TUFO A, Dunne DFJ, Manu N, Joshi H, et al
     Hepatectomy for octogenarians with colorectal liver metastasis in the era of enhanced recovery.
     Eur J Surg Oncol. 2018;44:1040-1047.
     PubMed     Abstract available
     
     
     June 2018
147. HARJI DP, Vallance A, Selgimann J, Bach S, et al
     A systematic analysis highlighting deficiencies in reported outcomes for patients with stage IV colorectal cancer undergoing palliative resection of the primary tumour.
     Eur J Surg Oncol. 2018 Jun 23. pii: S0748-7983(18)31134.
     PubMed     Abstract available
     
     
     
148. DE NEREE TOT BABBERICH MPM, Detering R, Dekker JWT, Elferink MA, et al
     Achievements in colorectal cancer care during 8 years of auditing in The Netherlands.
     Eur J Surg Oncol. 2018 Jun 8. pii: S0748-7983(18)31117.
     PubMed     Abstract available
     
     
     
149. QUINTANA JM, Anton-Ladisla A, Gonzalez N, Lazaro S, et al
     Outcomes of open versus laparoscopic surgery in patients with colon cancer.
     Eur J Surg Oncol. 2018 Jun 6. pii: S0748-7983(18)31110.
     PubMed     Abstract available
     
     
     
150. VAN VUGT JLA, Coebergh van den Braak RRJ, Lalmahomed ZS, Vrijland WW, et al
     Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer.
     Eur J Surg Oncol. 2018 Jun 6. pii: S0748-7983(18)31109.
     PubMed     Abstract available
     
     
     
151. POELEMEIJER YQM, Lijftogt N, Detering R, Fiocco M, et al
     Obesity as a determinant of perioperative and postoperative outcome in patients following colorectal cancer surgery: A population-based study (2009-2016).
     Eur J Surg Oncol. 2018 Jun 6. pii: S0748-7983(18)31104.
     PubMed     Abstract available
     
     
     
152. HAMMOUDI N, Eveno C, Lambert J, Maillet M, et al
     Inflammatory bowel disease drastically affects the prognosis of patients treated for peritoneal metastases with combined cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A multicenter study.
     Eur J Surg Oncol. 2018;44:799-804.
     PubMed     Abstract available
     
     
     
153. WANG K, Xu D, Yan XL, Poston G, et al
     The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
     Eur J Surg Oncol. 2018;44:771-777.
     PubMed     Abstract available
     
     
     
154. LO DICO R, Tijeras-Raballand A, Bonnin P, Launay JM, et al
     Hepatectomy increases metastatic graft and growth in an immunocompetent murine model of peritoneal metastases.
     Eur J Surg Oncol. 2018;44:784-791.
     PubMed     Abstract available
     
     
     
155. SUGARBAKER PH
     Peritoneal metastases invading the seminal vesicles: Radiologic appearance and outcome of treatment.
     Eur J Surg Oncol. 2018;44:805-809.
     PubMed     Abstract available
     
     
     May 2018
156. VALLANCE AE, van der Meulen J, Kuryba A, Braun M, et al
     Socioeconomic differences in selection for liver resection in metastatic colorectal cancer and the impact on survival.
     Eur J Surg Oncol. 2018 May 26. pii: S0748-7983(18)31078.
     PubMed     Abstract available
     
     
     
157. CLOYD JM, Mizuno T, Vauthey JN
     Reply to: Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer.
     Eur J Surg Oncol. 2018 May 18. pii: S0748-7983(18)31070.
     PubMed    
     
     
     
158. TRAUTMANN F, Reissfelder C, Pecqueux M, Weitz J, et al
     Evidence-based quality standards improve prognosis in colon cancer care.
     Eur J Surg Oncol. 2018 May 17. pii: S0748-7983(18)31067.
     PubMed     Abstract available
     
     
     
159. CRISTOBAL I, Torrejon B, Santos A, Luque M, et al
     Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer.
     Eur J Surg Oncol. 2018 May 9. pii: S0748-7983(18)31027.
     PubMed    
     
     
     
160. MIZUNO T, Cloyd JM, Vicente D, Omichi K, et al
     SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
     Eur J Surg Oncol. 2018;44:684-692.
     PubMed     Abstract available
     
     
     
161. FERNANDEZ JA, Gomez-Ruiz AJ, Olivares V, Ferri B, et al
     Clinical and pathological features of "small" GIST (</=2 cm). What is their prognostic value?
     Eur J Surg Oncol. 2018;44:580-586.
     PubMed     Abstract available
     
     
     April 2018
162. MINNELLA EM, Carli F
     Prehabilitation and functional recovery for colorectal cancer patients.
     Eur J Surg Oncol. 2018 Apr 30. pii: S0748-7983(18)31022.
     PubMed     Abstract available
     
     
     
163. DEGIULI M, Arolfo S, Evangelista A, Lorenzon L, et al
     Number of lymph nodes assessed has no prognostic impact in node-negative rectal cancers after neoadjuvant therapy. Results of the "Italian Society of Surgical Oncology (S.I.C.O.) Colorectal Cancer Network"(SICO-CCN) multicentre collaborative study.
     Eur J Surg Oncol. 2018 Apr 17. pii: S0748-7983(18)31012.
     PubMed     Abstract available
     
     
     
164. BROUWER NPM, Stijns RCH, Lemmens VEPP, Nagtegaal ID, et al
     Clinical lymph node staging in colorectal cancer; a flip of the coin?
     Eur J Surg Oncol. 2018 Apr 17. pii: S0748-7983(18)31013.
     PubMed     Abstract available
     
     
     
165. FALCAO D, Alexandrino H, Caetano Oliveira R, Martins J, et al
     Histopathologic patterns as markers of prognosis in patients undergoing hepatectomy for colorectal cancer liver metastases - Pushing growth as an independent risk factor for decreased survival.
     Eur J Surg Oncol. 2018 Apr 11. pii: S0748-7983(18)30992.
     PubMed     Abstract available
     
     
     
166. SHIDA D, Ochiai H, Tsukamoto S, Kanemitsu Y, et al
     Long-term outcomes of laparoscopic versus open D3 dissection for stage II/III colon cancer: Results of propensity score analyses.
     Eur J Surg Oncol. 2018 Apr 5. pii: S0748-7983(18)30991.
     PubMed     Abstract available
     
     
     
167. ITO M, Kobayashi A, Fujita S, Mizusawa J, et al
     Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG02
     Eur J Surg Oncol. 2018;44:463-468.
     PubMed     Abstract available
     
     
     
168. LORENZON L, Biondi A, Carus T, Dziki A, et al
     Achieving high quality standards in laparoscopic colon resection for cancer: A Delphi consensus-based position paper.
     Eur J Surg Oncol. 2018;44:469-483.
     PubMed     Abstract available
     
     
     
169. FIGUEIREDO N, Panteleimonitis S, Popeskou S, Cunha JF, et al
     Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
     Eur J Surg Oncol. 2018;44:484-489.
     PubMed     Abstract available
     
     
     
170. HUTTNER FJ, Warschkow R, Schmied BM, Diener MK, et al
     Prognostic impact of anastomotic leakage after elective colon resection for cancer - A propensity score matched analysis of 628 patients.
     Eur J Surg Oncol. 2018;44:456-462.
     PubMed     Abstract available
     
     
     March 2018
171. ZABALETA J, Iida T, Falcoz PE, Salah S, et al
     Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis.
     Eur J Surg Oncol. 2018 Mar 21. pii: S0748-7983(18)30957.
     PubMed     Abstract available
     
     
     
172. POLOM K, Boger C, Smyth E, Marrelli D, et al
     Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency.
     Eur J Surg Oncol. 2018 Mar 2. pii: S0748-7983(18)30882.
     PubMed     Abstract available
     
     
     February 2018
173. CASHIN PH, Mahteme H, Syk I, Frodin JE, et al
     Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastases.
     Eur J Surg Oncol. 2018 Feb 21. pii: S0748-7983(18)30672.
     PubMed     Abstract available
     
     
     
174. SHIM JR, Lee SD, Han SS, Lee SJ, et al
     Prognostic significance of (18)F-FDG PET/CT in patients with colorectal cancer liver metastases after hepatectomy.
     Eur J Surg Oncol. 2018 Feb 6. pii: S0748-7983(18)30292.
     PubMed     Abstract available
     
     
     
175. FURUKI H, Yamada T, Takahashi G, Iwai T, et al
     Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.
     Eur J Surg Oncol. 2018 Feb 2. pii: S0748-7983(18)30273.
     PubMed     Abstract available
     
     
     
176. STIJNS RCH, Tromp MR, Hugen N, de Wilt JHW, et al
     Advances in organ preserving strategies in rectal cancer patients.
     Eur J Surg Oncol. 2018;44:209-219.
     PubMed     Abstract available
     
     
     
177. PEREZ D, Melling N, Biebl M, Reeh M, et al
     Robotic low anterior resection versus transanal total mesorectal excision in rectal cancer: A comparison of 115 cases.
     Eur J Surg Oncol. 2018;44:237-242.
     PubMed     Abstract available
     
     
     
178. MORALES-SORIANO R, Esteve-Perez N, Segura-Sampedro JJ, Cascales-Campos P, et al
     Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey.
     Eur J Surg Oncol. 2018;44:228-236.
     PubMed     Abstract available
     
     
     January 2018
179. OKAMURA R, Hida K, Nishizaki D, Sugihara K, et al
     Proposal of a stage-specific surveillance strategy for colorectal cancer patients: A retrospective analysis of Japanese large cohort.
     Eur J Surg Oncol. 2018 Jan 31. pii: S0748-7983(18)30116.
     PubMed     Abstract available
     
     
     
180. SHEN Z, Lin Y, Ye Y, Jiang K, et al
     The development and validation of a novel model for predicting surgical complications in colorectal cancer of elderly patients: Results from 1008 cases.
     Eur J Surg Oncol. 2018 Jan 12. pii: S0748-7983(18)30034.
     PubMed     Abstract available
     
     
     
181. WESTBERG K, Palmer G, Hjern F, Johansson H, et al
     Management and prognosis of locally recurrent rectal cancer - A national population-based study.
     Eur J Surg Oncol. 2018;44:100-107.
     PubMed     Abstract available
     
     
     
182. SAO JULIAO GP, Habr-Gama A, Vailati BB, Aguilar PB, et al
     Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
     Eur J Surg Oncol. 2018;44:93-99.
     PubMed     Abstract available
     
     
     
183. OMICHI K, Shindoh J, Cloyd JM, Mizuno T, et al
     Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis.
     Eur J Surg Oncol. 2018;44:122-129.
     PubMed     Abstract available
     
     
     
184. STIFT J, Graf A, Schwarz C, Tamandl D, et al
     Microscopic biliary and perineural invasion and clinical outcome after neoadjuvant bevacizumab-based chemotherapy and liver resection in patients with colorectal liver metastases.
     Eur J Surg Oncol. 2018;44:139-147.
     PubMed     Abstract available
     
     
     
185. LINTER KAPISINSKA M, Hovorkova E, Zavalova V, Subrt Z, et al
     Distribution of metastases in mesorectum is unpredictable: Metastases do not respect tumor localization even in small non-circumferential rectal cancers.
     Eur J Surg Oncol. 2018;44:87-92.
     PubMed     Abstract available
     
     
     
186. DUPRE A, Malik HZ, Jones RP, Diaz-Nieto R, et al
     Influence of the primary tumour location in patients undergoing surgery for colorectal liver metastases.
     Eur J Surg Oncol. 2018;44:80-86.
     PubMed     Abstract available
     
     
     
187. SUTTON PA, Jithesh PV, Jones RP, Evans JP, et al
     Exome sequencing of synchronously resected primary colorectal tumours and colorectal liver metastases to inform oncosurgical management.
     Eur J Surg Oncol. 2018;44:115-121.
     PubMed     Abstract available
     
     
     
188. JONES HJS, Cunningham C, Nicholson GA, Hompes R, et al
     Outcomes following completion and salvage surgery for early rectal cancer: A systematic review.
     Eur J Surg Oncol. 2018;44:15-23.
     PubMed     Abstract available
     
     
     
189. HUISKENS J, Olthof PB, van der Stok EP, Bais T, et al
     Does portal vein embolization prior to liver resection influence the oncological outcomes - A propensity score matched comparison.
     Eur J Surg Oncol. 2018;44:108-114.
     PubMed     Abstract available
     
     
     December 2017
190. DESJARDIN M, Desolneux G, Brouste V, Degrandi O, et al
     Parenchymal sparing surgery for colorectal liver metastases: The need for a common definition.
     Eur J Surg Oncol. 2017;43:2285-2291.
     PubMed     Abstract available
     
     
     
191. CHAPELLE T, Op de Beeck B, Driessen A, Roeyen G, et al
     Estimation of the future remnant liver function is a better tool to predict post-hepatectomy liver failure than platelet-based liver scores.
     Eur J Surg Oncol. 2017;43:2277-2284.
     PubMed     Abstract available
     
     
     November 2017
192. REHA J, Mukkamalla SKR, Rathore R, Somasundar PS, et al
     Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I-III colon cancer: A validation study using the National Cancer Data Base.
     Eur J Surg Oncol. 2017 Nov 23. pii: S0748-7983(17)30966.
     PubMed     Abstract available
     
     
     
193. VAN EDEN WJ, Kok NFM, Woensdregt K, Huitema ADR, et al
     Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC.
     Eur J Surg Oncol. 2017 Nov 15. pii: S0748-7983(17)30956.
     PubMed     Abstract available
     
     
     
194. OFFERMANS T, Vogelaar FJ, Aquarius M, Janssen-Heijnen MLG, et al
     Preoperative segmental localization of colorectal carcinoma: CT colonography vs. optical colonoscopy.
     Eur J Surg Oncol. 2017;43:2105-2111.
     PubMed     Abstract available
     
     
     
195. YOUNG CJ, Zahid A, Choy I, Thompson JF, et al
     Incidental detection of colorectal lesions by FDG PET/CT scans in melanoma patients.
     Eur J Surg Oncol. 2017;43:2163-2169.
     PubMed     Abstract available
     
     
     
196. SIDDIQUI MRS, Shanmuganandan AP, Rasheed S, Tekkis P, et al
     An audit comparing the reporting of staging MRI scans for rectal cancer with the London Cancer Alliance (LCA) guidelines.
     Eur J Surg Oncol. 2017;43:2093-2104.
     PubMed     Abstract available
     
     
     
197. GASH KJ, Baser O, Kiran RP
     Factors associated with degree of tumour response to neo-adjuvant radiotherapy in rectal cancer and subsequent corresponding outcomes.
     Eur J Surg Oncol. 2017;43:2052-2059.
     PubMed     Abstract available
     
     
     
198. HELDENS AFJM, Bongers BC, Lenssen AF, Stassen LPS, et al
     The association between performance parameters of physical fitness and postoperative outcomes in patients undergoing colorectal surgery: An evaluation of care data.
     Eur J Surg Oncol. 2017;43:2084-2092.
     PubMed     Abstract available
     
     
     
199. LEE SH, Lee JL, Kim CW, Lee HI, et al
     Oncologic significance of para-aortic lymph node and inferior mesenteric lymph node metastasis in sigmoid and rectal adenocarcinoma.
     Eur J Surg Oncol. 2017;43:2076-2083.
     PubMed     Abstract available
     
     
     
200. PETZ W, Ribero D, Bertani E, Borin S, et al
     Suprapubic approach for robotic complete mesocolic excision in right colectomy: Oncologic safety and short-term outcomes of an original technique.
     Eur J Surg Oncol. 2017;43:2060-2066.
     PubMed     Abstract available
     
     
     October 2017
201. DUPRE A, Jones RP, Diaz-Nieto R, Fenwick SW, et al
     Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
     Eur J Surg Oncol. 2017;43:1901-1907.
     PubMed     Abstract available
     
     
     
202. SUN Y, Xu Z, Lin H, Lu X, et al
     Impact of body mass index on treatment outcome of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
     Eur J Surg Oncol. 2017;43:1828-1834.
     PubMed     Abstract available
     
     
     
203. JONKER FHW, Hagemans JAW, Verhoef C, Burger JWA, et al
     The impact of hospital volume on perioperative outcomes of rectal cancer.
     Eur J Surg Oncol. 2017;43:1894-1900.
     PubMed     Abstract available
     
     
     
204. KVERNENG HULTBERG D, Angenete E, Lydrup ML, Rutegard J, et al
     Nonsteroidal anti-inflammatory drugs and the risk of anastomotic leakage after anterior resection for rectal cancer.
     Eur J Surg Oncol. 2017;43:1908-1914.
     PubMed     Abstract available
     
     
     
205. SOLON JG, O'Neill M, Chang KH, Deady S, et al
     An 18 year population-based study on site of origin and outcome of patients with peritoneal malignancy in Ireland.
     Eur J Surg Oncol. 2017;43:1924-1931.
     PubMed     Abstract available
     
     
     September 2017
206. DUWE G, Knitter S, Pesthy S, Beierle AS, et al
     Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection.
     Eur J Surg Oncol. 2017;43:1668-1681.
     PubMed     Abstract available
     
     
     August 2017
207. BIN TRAIKI TA, Fisher OM, Valle SJ, Parikh RN, et al
     Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis.
     Eur J Surg Oncol. 2017 Aug 31. pii: S0748-7983(17)30639.
     PubMed     Abstract available
     
     
     
208. CURRIE AC, Brigic A, Thomas-Gibson S, Suzuki N, et al
     A pilot study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative sentinel lymph node mapping in early colon cancer.
     Eur J Surg Oncol. 2017 Aug 23. pii: S0748-7983(17)30643.
     PubMed     Abstract available
     
     
     
209. POSTON G, Adam R, Xu J, Byrne B, et al
     The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection.
     Eur J Surg Oncol. 2017 Aug 10. pii: S0748-7983(17)30605.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: